Tag: JDST

Blue Horseshoe Stocks: PVSP Update, PLUG News & More

Pervasip Corp. PVSP

For the second consecutive session, PVSP made higher highs and higher lows yesterday. We re-focused on this old favorite at the end of last week, and caught it trading at a low of .0014. After a solid session to close out the holiday-shortened week, we once again included it in our premarket report yesterday, and the stock kicked this week off on a strong note as well.

We observed a trading range from .0015 to .0021, a 40% intraday push, and an overall range of 50% over our observed low from Thursday.

The heathly activity on the chart can be attributed in part to last week’s acquisition news; PVSP now holds, through its newly-acquired subsidiary, a 60% stake in Denver-based distribution company servicing the hydroponic and indoor cannabis grow market>> Read PR

Plug Power, Inc. PLUG

Speaking of old favorites, PLUG has published a PR today which is standing out among this morning’s top news items, with a very promising announcement of their Q2 figures. Perhaps one of the most notable aspects; the company shipped more than twice as many of its GenDrive fuel cell units as it did in the previous quarter.

This news comes at an opportune time, with the stock having been undergoing a recent downtrend which culminated in the logging of a new 52-week low yesterday. We’re anxious to follow the activity after what is looking like a significant gap-up this morning, in what could turn into a noteworthy rebound-play.

LATHAM, N.Y., July 7, 2015 (GLOBE NEWSWIRE) — Plug Power Inc. (PLUG), a leader in providing clean, reliable energy solutions, today highlighted strong fuel cell and hydrogen infrastructure shipments and installations in the second quarter of 2015 allowing for a record revenue quarter. The company is on track to achieve its previously announced 2015 financial targets. >> FULL PR

Prima BioMed, Ltd. PBMD

Also cropping up on our news scanner this morning is PBMD. It’s no secret that we’ve had an exceptional amount of success with various pharma plays this year, and this could be the next entry into that group.

This morning’s news suggests that the company’s flagship product, a metastatic breast cancer treatment, could be on the path to approval for European markets. The stock is trading at its lowest price since May.

SYDNEY, AUSTRALIA–(Marketwired – Jul 7, 2015) – Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (“Prima” or the “Company”), a leading immuno-oncology company, is pleased to announce that it has received positive Scientific Advice from the European Medicines Agency (“EMA” or the “Agency”) on the development path for its lead product, IMP321 in metastatic breast cancer. >> FULL PR

Extended Watchlist:
ORMP, JDST, MDBX, KALO(Bottom-Watch), OCFN (Possible Momentum-Play)

Blue Horseshoe Stocks: TSLA Options Recap & More

Tesla Motors, Inc. TSLA – Options

Despite another choppy day for the markets as a whole, we were able to find a diamond in the rough with our TSLA Options Idea in Thursday’s premarket report.

As the stock was gapping up, we identified the possibility of some dip-and-rip scenarios occurring in weekly TSLA $275-280 Calls and that’s precisely what we got. There was some extremely impressive action with the $275’s and $277.50’s in particular, that could’ve provided traders with exponential gains.

The $275 Calls jumped out of the starting gate and went on an initial run from 5.00 to 7.60 (+52%) in the first couple minutes of the session. The dip-and-rip we were after provided an even bigger opportunity as the contracts reached a midday low of .78 before rebounding, and absolutely exploded back to a 5.10 close. That marked a second intraday rip of 554%

The $277.50’s traded in a similar pattern; the initial move was from 3.20 to 5.40 (+69%), and their dip took them to a low of .21 before re-launching as high as 3.00 into the close. That was a mind-boggling 1329% rip.

NuGene International, Inc. NUGN

NUGN has been an ongoing point of interest for us over the past few weeks; we alerted the stock in the third week of June, and at that time, observed a 2.67 swing-low. Since then, the chart has been on a steady incline, surging as much as 47% as it hit a high of 3.88 on both Wednesday and Thursday.

We’ll be looking for the possibility of the stock cracking through that resistance to continue its uptrend into this week.

There’s a fresh PR coming off of the wire this morning as well:

IRVINE, Calif., July 6, 2015 /PRNewswire/ — NuGene International, Inc. (“NuGene”) (NUGN), a developer, manufacturer and marketer of advanced skin and hair care lines utilizing adipose derived human stem cells and stem cell media, conducted one-on-one meetings with top beauty editors in New York City including Allure, Vogue, Glamour, Marie Claire, Self, Shape, More, Town and Country, People, People Style Watch, Cosmopolitan, Better Homes and Gardens and W. >> View PR

Extended Watchlist:
PVSP, WTW, ONCY, JDST, CLSN, ASTI, ENZN

Blue Horseshoe Stocks: SOPW News, PTN on Bottom Watch

Solar Power, Inc. SOPW

SOPW is the first of a couple of news plays that we’re going to be taking a look at this morning. The company has announced the initiation of a 6-month long share repurchase program wherein it will obtain up to $50M of its common stock from the open market.

Xiaofeng Peng, Chairman of SPI stated, “The implementation of our share repurchase program reflects the confidence that our Board and management have in SPI’s growth prospects and our commitment to enhance value for our shareholders while retaining adequate flexibility for future growth.” >>> READ FULL PR

In addition to the favorable PR that, in and of itself would be enough to gain our attention, SOPW has also been searching for a bottom over the past few weeks, and we’ll want to be hanging around when it finds one, as the subsequent rebound could be considerable.

Palatin Technologies, Inc. PTN

PTN has capitalized on the FDA’s recommendation for the first ever treatment for a disorder that affects the female sex drive. The company itself has a similar treatment that is currently enrolling women for Phase-3 trials.

As a result of this heightened attention, this morning, the stock is gapping up over 50% in the premarket. We’re going to tag it for observation, because the potential for a dip-and-rip in situations like these is ever-present.

LinkedIn Corp. LNKD –  Options

Our LNKD Weekly Options Calls that we brought into the mix on Wednesday continued to pay dividends for the second consecutive session yesterday. We wanted to give a quick update on the ranges and total gains that have been possible with those contracts over a two-day span:

$205′s – Range: 6.00-11.64 – Max Gain: 94%
$207.50′s – Range: 4.20-9.29 – Max Gain: 119%
$210′s – Range: 2.60-7.30 – Max Gain: 181%
$212.50′s – Range: 1.58-5.10 – Max Gain: 223%

We want to extend our congratulations to anyone who joined us in taking advantage of the trend in LNKD this week. It wasn’t the first time we’ve made successful options calls on this stock, and it probably won’t be the last.

Extended Watchlist:
ICLD, INO, JDST, OCLS